U 785 (Glipizide and Metformin 2.5 mg / 500 mg)
Pill imprint U 785 has been identified as Glipizide and metformin hydrochloride 2.5 mg / 500 mg.
Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glipizide/metformin 2.5 mg / 500 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- U 785
- Strength:
- 2.5 mg / 500 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- USV Limited
- National Drug Code (NDC):
- 23155-0116
- Inactive Ingredients:
- sodium starch glycolate type A potato
corn starch
povidone
magnesium stearate
silicon dioxide
hypromellose 2910 (15 mPa.s)
magnesium silicate
titanium dioxide
polyethylene glycol 6000
propylene glycol
More about glipizide/metformin
Consumer resources
- Other brands: Metaglip
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
